About: Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
Creator	Koh, Younsuck Loeb, Mark Cecconi, Maurizio Citerio, Giuseppe Hayden, Frederick Arabi, Yaseen Evans, Laura Maitland, Kathryn Memish, Ziad Rhodes, Andrew Alhazzani, Waleed Alshamsi, Fayez Fan, Eddy Wunsch, Hannah Chertow, Daniel Gong, Michelle Hammond, Naomi Mcgeer, Allison Mermel, Leonard Arrington, Amy Morgan, Jill Aboodi, Michael Alexander, Paul Baw, Bandar Belley-Cote, Emilie Centofanti, John Derde, Lennie Dzierba, Amy Greco, Massimiliano Kesecioglu, Jozef Laundy, Matthew Levy, Mitchell Mammen, Manoj Møller, Morten Oczkowski, Simon Org, Www
Source	Medline; PMC
abstract	The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting thousands of people around the world. Urgent guidance for clinicians caring for the sickest of these patients is needed. METHODS: We formed a panel of 36 experts from 12 countries. All panel members completed the World Health Organization conflict of interest disclosure form. The panel proposed 53 questions that are relevant to the management of COVID-19 in the ICU. We searched the literature for direct and indirect evidence on the management of COVID-19 in critically ill patients in the ICU. We identified relevant and recent systematic reviews on most questions relating to supportive care. We assessed the certainty in the evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, then generated recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility. Recommendations were either strong or weak, or in the form of best practice recommendations. RESULTS: The Surviving Sepsis Campaign COVID-19 panel issued 54 statements, of which four are best practice statements, nine are strong recommendations, and 35 are weak recommendations. No recommendation was provided for six questions. The topics were: 1) infection control, 2) laboratory diagnosis and specimens, 3) hemodynamic support, 4) ventilatory support, and 5) COVID-19 therapy. CONCLUSION: The Surviving Sepsis Campaign COVID-19 panel issued several recommendations to help support healthcare workers caring for critically ill ICU patients with COVID-19. When available, we will provide new evidence in further releases of these guidelines.
has issue date	2020-04-21(xsd:dateTime)
bibo:doi	10.1097/ccm.0000000000004363
bibo:pmid	32224769
has license	no-cc
sha1sum (hex)	052b38372edaeb916fa711a29c74cef7c57ab0ba
schema:url	https://doi.org/10.1097/ccm.0000000000004363
resource representing a document's title	Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
has PubMed Central identifier	PMC7176264
has PubMed identifier	32224769
schema:publication	Crit Care Med
resource representing a document's body	covid:052b38372edaeb916fa711a29c74cef7c57ab0ba#body_text
is schema:about of	named entity 'Department' named entity 'Anaesthesiology' named entity 'hypoxemic' named entity 'healthcare workers' named entity 'seasonal influenza' named entity 'COVID-19' named entity 'COVID-19 deaths' named entity 'blood transfusion' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'colloids' named entity 'environmental contamination' named entity 'CFR' named entity 'lower respiratory tract' named entity 'thromboembolism' named entity 'RT-PCR' named entity 'oxygen' named entity 'Surviving Sepsis Campaign' named entity 'critically ill patients' named entity 'COVID' named entity 'RNA chains' named entity 'meta-analysis' named entity 'ICU' named entity 'MERS' named entity 'SARS' named entity 'blood transfusion' named entity 'ECMO' named entity 'second-line' named entity 'therapeutic agents' named entity 'acetaminophen/paracetamol' named entity 'epinephrine' named entity 'COI' named entity 'NIPPV' named entity 'standing committee' named entity 'World Health Organization' named entity 'albumin' named entity 'WHO' named entity 'COVID-19' named entity 'NIPPV' named entity 'ICU' named entity 'COVID-19' named entity 'ARDS' named entity 'NIPPV' named entity 'hydroxyethyl' named entity 'diabetes' named entity 'antiretroviral'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software